Showing metabocard for Oxyplicacetin (MMDBc0060797)
Microbial
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 2.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-02 23:16:31 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:21 UTC | ||||||||||||
| Metabolite ID | MMDBc0060797 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | Oxyplicacetin | ||||||||||||
| Description | Oxyplicacetin is a nucleoside antibiotic belonging to the class of cytosaminomycins. Its chemical structure features a unique arrangement of nucleoside components, characterized by specific carboxylic acid moieties that differentiate it from related compounds. The distinct bonding of these moieties to the cytosine residue is a notable aspect of oxyplicacetin's structure, as highlighted in the literature (PMID:8071123 ). In terms of biochemical pathways, oxyplicacetin is involved in various cellular processes, particularly those related to nucleic acid metabolism and antibiotic activity. Its role as a metabolite suggests that it may participate in the modulation of cellular functions, potentially influencing the synthesis or degradation of nucleic acids. The interactions and mechanisms of action of oxyplicacetin, along with its structural analogs, continue to be a subject of research, contributing to our understanding of nucleoside antibiotics and their therapeutic potential (PMID:8071123 ). | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C25H35N5O8 | ||||||||||||
| Average Mass | 533.582 | ||||||||||||
| Monoisotopic Mass | 533.248563107 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | NJRKCURACRGUML-UHFFFAOYNA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | NJRKCURACRGUML-UHFFFAOYSA-N | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References |
| ||||||||||||
